针对肺癌的新型疫苗
Sofia Baka1, George Iraklis, Evanthia Papadopoulou
1Molecular Medicine Clinic, Aristotle University of Thessaloniki, Greece.
Current opinion in oncology
|October 1, 2024
概括
治疗非小细胞肺癌 (NSCLC) 的治疗疫苗有希望,特别是个性化新抗原疫苗. 传递系统和组合疗法的进步旨在改善免疫反应和肺癌治疗患者的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 免疫疗法已经推进了非小细胞肺癌 (NSCLC) 治疗.
- 对于NSCLC,需要进一步发展免疫瘤学,特别是治疗性疫苗接种.
研究的目的:
- 审查肺癌治疗疫苗的最新进展.
- 探索抗原选择和输送平台的战略.
- 总结临床试验,作用机制和新型肺癌疫苗的数据.
主要方法:
- 关于肺癌治疗疫苗的最新文献的综述.
- 分析正在进行的临床试验及其结果 (截至2024年8月5日).
- 对抗原选择策略和输送平台的评估.
主要成果:
- 肺癌治疗疫苗的过去临床试验结果是混合的.
- 下一代测序和生物信息学有助于识别合适的新抗原.
- 新型个性化疫苗针对特定于独特瘤突变的新抗原.
结论:
- 个性化的新抗原疫苗,改进的输送系统和辅助剂可以增强抗原呈现和免疫激活.
- 将治疗性疫苗与其他治疗方法结合起来,对于改善和延长NSCLC的反应至关重要.
- 未来的方向侧重于新抗原,而不是与瘤相关的抗原,以获得更好的疗效.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.7K
12:43Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
11.8K
相关概念视频
01:30Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
01:03Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K